Eniluracil

Overview

Eniluracil (5-Ethynyluracil) is an orally active dihydropyrimidine dehydrogenase ( DPD ) inhibitor. Eniluracil irreversibly inhibits DPD , increases the oral bioavailability of 5-fluorouracil to 100%, and facilitates the uniform absorption and toxicity of 5-fluorouracil. Eniluracil can be used in cancer research of combination with fluoropyrimidines (including 5-fluorouracil). Eniluracil is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Application

Products | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Biochemical Assay Reagents

Product Information

• Catalog No.: HY-10533
• CAS No.: 59989-18-3
• Molecular Formula: C6H4N2O2
• Molecular Weight: 136.11
• Purity: 99.87%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 0.56 mg/mL (4.11 mM); Clear solution
• Availability: In-stock

Source

Original product source